Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders

By Baca E.   Garcia-Garcia M.   Porras-Chavarino A.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. : 57-65

Elsevier

Access to resources Recommend Favorite

Dose–response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder

By Bech Per   Kajdasz Daniel   Porsdal Vibeke  

Psychopharmacology, Vol. 188, Iss. 3, 2006-10 ,pp. : 273-280

Springer Publishing Company

Access to resources Recommend Favorite

Assessment of the evolution of anxiety during a treatment of major depressive disorders in ambulatory patients in general practice with fluoxetine (Prozac) 20 mg

By Mesters P.   Martens S.   Taymans J.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 290-291

Elsevier

Access to resources Recommend Favorite

Onset of action of fluoxetine 20 mg (Prozac) among ambulatory patients suffering from depressive disorders

By Mesters P.   Sangeleer M.   Bussios G.   Bourgeois M.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 291-291

Elsevier

Access to resources Recommend Favorite

Olanzapine/Fluoxetine: A Review of its Use in Patients With Treatment-Resistant Major Depressive Disorder

By Croxtall Jamie D.   Scott Lesley J.  

CNS Drugs, Vol. 24, Iss. 3, 2010-03 ,pp. : 245-262

Adis International

Access to resources Recommend Favorite